Page last updated: 2024-08-21

ethambutol and Latent Tuberculosis

ethambutol has been researched along with Latent Tuberculosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J1
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E1
George, S; Gerbo, RM; Hartman-Adams, H1
Marks, SM; Mase, SR; Morris, SB1
Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X1
Chinnakotla, S; Hassan, MA; Obeid, KM; Young, JH1
Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK1
Allen, SJ; Carlson, SL; Furukawa, NW; Haider, MZ; Lindquist, SW1
Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G1

Reviews

2 review(s) available for ethambutol and Latent Tuberculosis

ArticleYear
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-15, Volume: 64, Issue:12

    Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Latent Tuberculosis; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2017
Antitubercular therapy in patients with cirrhosis: challenges and options.
    World journal of gastroenterology, 2014, May-21, Volume: 20, Issue:19

    Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2014

Other Studies

7 other study(ies) available for ethambutol and Latent Tuberculosis

ArticleYear
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Journal of medicinal chemistry, 2016, Mar-24, Volume: 59, Issue:6

    Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles

2016
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Bioorganic & medicinal chemistry letters, 2016, May-01, Volume: 26, Issue:9

    Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant

2016
Tuberculosis: Common Questions and Answers.
    American family physician, 2022, Volume: 106, Issue:3

    Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States

2022
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
    American journal of ophthalmology, 2018, Volume: 190

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis; Visual Acuity

2018
Genitourinary Tract Infection Due to Mycobacterium avium intracellulare Complex Infection in Pretransplant Setting With Recurrence Following Transplant: A Case Report.
    Transplantation proceedings, 2018, Volume: 50, Issue:10

    Topics: Anti-Bacterial Agents; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Kidney Transplantation; Latent Tuberculosis; Liver Transplantation; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence; Urinary Tract Infections

2018
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
    The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Mexico; Middle Aged; Multivariate Analysis; Philippines; Pyrazinamide; Rifampin; Risk Factors; Vietnam; Washington; Young Adult

2017
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant

2012